Community Pharmacists Behaviour During Covid-19

NCT ID: NCT04374513

Last Updated: 2021-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

318 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-02

Study Completion Date

2020-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During the COVID-19 pandemic, governments issued movement restrictions and placed areas into quarantine to reduce the spread of the disease.Community pharmacists and their teams are a vital healthcare provider during the outbreak; they remain on the frontline of public health by serving as direct points of access for their patients. The retail pharmacists should provide public community, costumers and patients with right and trusted information about covid-19. They also should have role in awareness spreading regarding personnel safety and hygiene

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The survey will enroll as many community pharmacists as possible in the survey portion of the study - The number of participates have no limitations, at least 50 participants.

The survey will be enrolled in online google form, face to face interview \& semi-structured telephone interviews if possible.

The research procedures:

1. An online survey link will include questions regarding the impact of role and behavior of retail pharmacists during covid-19 outbreak.
2. Face to face and semi-structured interviews if possible: For those pharmacists who state that they would like to participate in an interview, a random sample will be contacted.

Inclusion Criteria:

1. Post graduated pharmacist.
2. Community pharmacists.

Exclusion Criteria:

1. under graduated students.
2. not pharmacist.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Post graduated pharmacist. Community pharmacists.

Exclusion Criteria

* under graduated students. not pharmacist.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Damanhour University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Asser Ghoneim, phD

Role: PRINCIPAL_INVESTIGATOR

Professor in Pharmacology, Faculty of pharmacy, Damanhour University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Damanhour university

Beheira, Damanhour, Egypt

Site Status

Damanhour universty

Alexandria, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Farooq A, Laato S, Islam AKMN. Impact of Online Information on Self-Isolation Intention During the COVID-19 Pandemic: Cross-Sectional Study. J Med Internet Res. 2020 May 6;22(5):e19128. doi: 10.2196/19128.

Reference Type BACKGROUND
PMID: 32330115 (View on PubMed)

Bukhari N, Rasheed H, Nayyer B, Babar ZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020 Apr 20;13:8. doi: 10.1186/s40545-020-00210-w. eCollection 2020.

Reference Type BACKGROUND
PMID: 32328285 (View on PubMed)

Rutter V, Chan AHY, Tuck C, Bader L, Babar ZU, Bates I. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. J Pharm Policy Pract. 2018 Apr 11;11:10. doi: 10.1186/s40545-018-0140-3. eCollection 2018.

Reference Type BACKGROUND
PMID: 29651337 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pharmacists and covid-19

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Pharmacist Impact Study
NCT07269002 COMPLETED NA